Abstract

No AccessJournal of UrologyEditorial1 May 2022Prostate Cancer, Decisional Regret and Exercise Scott Eggener, and D. Robert Siemens Scott EggenerScott Eggener More articles by this author , and D. Robert SiemensD. Robert Siemens More articles by this author View All Author Informationhttps://doi.org/10.1097/JU.0000000000002453AboutFull TextPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissionsReprints ShareFacebookLinked InTwitterEmail "Prostate Cancer, Decisional Regret and Exercise." The Journal of Urology, 207(5), pp. 952–953 REFERENCES 1. : The Paradox of Choice: Why More Is Less. New York: HarperCollins Publishers 2004. Google Scholar 2. : Treatment decision regret among long-term survivors of localized prostate cancer: results from the Prostate Cancer Outcomes Study. J Clin Oncol 2017; 35: 2306. Google Scholar 3. : Why do patients regret their prostate cancer treatment? A systematic review of regret after treatment for localized prostate cancer. Psychooncology 2015; 24: 1002. Google Scholar 4. : Association of treatment modality, functional outcomes, and baseline characteristics with treatment-related regret among men with localized prostate cancer. JAMA Oncol 2021; 8: 50. Google Scholar 5. : Representation in online prostate cancer content lacks racial and ethnic diversity: implications for Black and Latinx men. J Urol 2022; 207: 559. Link, Google Scholar 6. : Treatment in the absence of disease reclassification among men on active surveillance for prostate cancer. Cancer 2022; 128: 269. Google Scholar 7. : Relationship between illness uncertainty, anxiety, fear of progression and quality of life in men with favourable-risk prostate cancer undergoing active surveillance. BJU Int 2016; 117: 469. Google Scholar 8. Kang Google Scholar, Fairey, Boulé: A randomized trial of the effects of exercise on anxiety, fear of cancer progression and quality of life in prostate cancer patients on active surveillance. J Urol 2022; 207: 814. Link, Google Scholar 9. : Effects of exercise on cardiorespiratory fitness and biochemical progression in men with localized prostate cancer under active surveillance: the ERASE randomized clinical trial. JAMA Oncol 2021; 7: 1487. Google Scholar Google Scholar © 2022 by American Urological Association Education and Research, Inc.FiguresReferencesRelatedDetails Volume 207Issue 5May 2022Page: 952-953 Advertisement Copyright & Permissions© 2022 by American Urological Association Education and Research, Inc.MetricsAuthor Information Scott Eggener More articles by this author D. Robert Siemens More articles by this author Expand All Advertisement PDF DownloadLoading ...

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.